Trending:
MSP-1014

Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved Safety in Head-to-Head Comparison to Psilocybin for its First Lead Clinical Candidate, MSP-1014 MSP-1014, a next generation psychedelic medicine showed superior 5-HT2A receptor efficacy and safety compared to psilocybin

July 7, 2021

Ryan Allway July 7th, 2021 Psychedelics TORONTO, July 07, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery and development company focused on creating optimized next-generation psychedelic medicines to treat neurological and neuropsychiatric disorders with unmet medical needs, today announced... Read more
Recent Comments
California’s Cannabis Lounges and Assembly Bill 374: Food, Fun, Weed

California’s Cannabis Lounges and Assembly Bill 374: Food, Fun, Weed

Uncategorized Jun 4, 2024

Texas Senate Hearing On Hemp Also Touches On Medical Cannabis And Broader Marijuana Legalization Issues

Marijuana Industry Jun 4, 2024 0

GOP Congressional Committee Removes D.C. Marijuana Sales Ban And Adds Cannabis Banking Protections In Key Spending Bill

Featured Jun 4, 2024 0

New Hampshire House Lawmakers Offer Senators A Marijuana Legalization Compromise At Conference Committee Meeting

Featured Jun 4, 2024 0

High Tide Inc. (HITI) Welcomes Alberta’s Decision to Allow Private Label Cannabis Sales

High Tide Inc. (HITI) Welcomes Alberta’s Decision to Allow Private Label Cannabis Sales

Marijuana Industry News Jun 4, 2024

The Green Organic Dutchman Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada

The Green Organic Dutchman Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada

Marijuana Stocks, Finance, & Investing Jan 3, 2019 1

Copyright © 2018 MJShareholders.com - All Rights Reserved
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )